Direktorat Registrasi ObatValid

ALBENDAZOLE

Claim this product
BPOM Number
GKL2117115133A1
Approved
29 October 2025
Expiry
28 October 2030
Form
Suspension

About This Registration

ALBENDAZOLE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2117115133A1. Its current registration status is Valid, with the licence valid until 28 October 2030. The product is registered to HOLI PHARMA - INDONESIA. BPOM first approved this registration in October 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 1 BOTOL @ 10 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

ALBENDAZOLE

Market Intelligence

Owner Portfolio
HOLI PHARMA - INDONESIA holds 132 BPOM registrations
Manufacturer Scale
HOLI PHARMA - INDONESIA produces 132 registered products
Registration Age
Registered for 8 months

FDA Cross-Reference

via openFDA
Generic Name
ALBENDAZOLE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1